Cargando…

Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide

The highly conserved extracellular domain of the transmembrane protein M2 (M2e) of the influenza A virus is a promising target for the development of broad-spectrum vaccines. However, M2e is a poor immunogen by itself and must be linked to an appropriate carrier to induce an efficient immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zykova, Anna A., Blokhina, Elena A., Kotlyarov, Roman Y., Stepanova, Liudmila A., Tsybalova, Liudmila M., Kuprianov, Victor V., Ravin, Nikolai V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601894/ https://www.ncbi.nlm.nih.gov/pubmed/33036278 http://dx.doi.org/10.3390/v12101133

Ejemplares similares

Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection
por: Zykova, Anna A., et al.
Publicado: (2023)

Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
por: Mardanova, Eugenia S., et al.
Publicado: (2015)

Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope
por: Blokhina, Elena A., et al.
Publicado: (2023)

Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin
por: Blokhina, Elena A., et al.
Publicado: (2020)

Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
por: Tsybalova, Liudmila M., et al.
Publicado: (2018)

Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
por: Stepanova, Liudmila A., et al.
Publicado: (2015)

Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes
por: Stepanova, Liudmila A., et al.
Publicado: (2018)

Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein
por: Kotlyarov, R.Y., et al.
Publicado: (2010)

Influenza B: Prospects for the Development of Cross-Protective Vaccines
por: Tsybalova, Liudmila M., et al.
Publicado: (2022)

Efficient Transient Expression of Recombinant Proteins in Plants by the Novel pEff Vector Based on the Genome of Potato Virus X
por: Mardanova, Eugenia S., et al.
Publicado: (2017)

Influence of the Linking Order of Fragments of HA2 and M2e of the influenza A Virus to Flagellin on the Properties of Recombinant Proteins
por: Stepanova, L. A., et al.
Publicado: (2018)

Rapid Transient Expression of Receptor-Binding Domain of SARS-CoV-2 and the Conserved M2e Peptide of Influenza A Virus Linked to Flagellin in Nicotiana benthamiana Plants Using Self-Replicating Viral Vector
por: Mardanova, Eugenia S., et al.
Publicado: (2022)

Comparative Immunological Study in Mice of Inactivated Influenza Vaccines Used in the Russian Immunization Program
por: Shanko, Andrei, et al.
Publicado: (2020)

A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity
por: Stepanova, L. A., et al.
Publicado: (2016)

Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines
por: Stepanova, Liudmila A., et al.
Publicado: (2022)

High-Yield Production of Receptor Binding Domain of SARS-CoV-2 Linked to Bacterial Flagellin in Plants Using Self-Replicating Viral Vector pEff
por: Mardanova, Eugenia S., et al.
Publicado: (2021)

Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of Influenza A virus
por: Dukhovlinov, Ilya, et al.
Publicado: (2013)

High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors
por: Mardanova, Eugenia S., et al.
Publicado: (2022)

Metagenome of the Microbial Community of Anammox Granules in a Nitritation/Anammox Wastewater Treatment System
por: Mardanov, Andrey V., et al.
Publicado: (2017)

Immunogenicity of a Fusion Protein Comprising Coli Surface Antigen 3 and Labile B Subunit of Enterotoxigenic Escherichia coli
por: Alerasol, Masoome, et al.
Publicado: (2014)

Metagenomic data of the microbial community of lab-scale nitritation-anammox sequencing-batch bioreactor performing nitrogen removal from synthetic wastewater
por: Mardanov, Andrey V., et al.
Publicado: (2019)

Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates
por: Mathieu, Cyrille, et al.
Publicado: (2018)

Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins
por: Tussey, Lynda, et al.
Publicado: (2016)

Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs
por: Shekunov, Egor V., et al.
Publicado: (2023)

P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009)

Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
por: Yang, Jian, et al.
Publicado: (2016)

Transgenic Carrot Expressing Fusion Protein Comprising M. tuberculosis Antigens Induces Immune Response in Mice
por: Permyakova, Natalia V., et al.
Publicado: (2015)

Immunogenic epitope prediction to create a universal influenza vaccine
por: Mintaev, R.R., et al.
Publicado: (2022)

Lipopeptides for Vaccine Development
por: Hamley, Ian W.
Publicado: (2021)

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
por: Schmitz, Katharina S., et al.
Publicado: (2022)

Expression and Immunogenicity of Two Recombinant Fusion Proteins Comprising Foot-and-Mouth Disease Virus Structural Protein VP1 and DC-SIGN-Binding Glycoproteins
por: Liu, Xinsheng, et al.
Publicado: (2017)

Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2020)

“CLipP”ing on lipids to generate antibacterial lipopeptides
por: Yim, Victor, et al.
Publicado: (2020)

Iturin: A Promising Cyclic Lipopeptide with Diverse Applications
por: Yaraguppi, Deepak A., et al.
Publicado: (2023)

Characterization of Influenza Vaccine Immunogenicity Using Influenza Antigen Microarrays
por: Price, Jordan V., et al.
Publicado: (2013)

Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
por: Lan, Qiaoshuai, et al.
Publicado: (2021)

Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides
por: Zhu, Yuanmei, et al.
Publicado: (2022)

Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2021)

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
por: Stepanova, Ekaterina, et al.
Publicado: (2021)

Viennamycins: Lipopeptides Produced by a Streptomyces sp.
por: Bekiesch, Paulina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8djgngoj5jtcqmup05v91theph